On the opening day of the EASL International Liver Congress taking place in Vienna, Austria, the International Coalition to Eliminate HBV (ICE-HBV), a global group of researchers, patient representatives and health organisations, will launch a Global Scientific Strategy to Cure Hepatitis B. The Strategy will be published simultaneously in The Lancet Gastroenterology & Hepatology and webcast live at https://ilc-congress.eu/
What: Launch of the ICE-HBV Global Scientific Strategy to Cure Hepatitis B at the European Association for the Study of the Liver (EASL) The International Liver Congress
Where: Press Conference Room, (Lehar 1), Ground floor, Reed Messe Wien Congress and Exhibition Center, Trabennstraße 7, 1020 Vienna, Austria
When: 11:30 CEST, Wednesday, 10th April
Who:
• Professor Peter Revill, ICE-HBV Chair at the Doherty Institute, Melbourne, Australia
• Professor Anna Suk-Fong Lok, Alice Lohrman Andrews Research Professor in Hepatology at the Department of Internal Medicine at the University of Michigan Health System in Ann Arbor, MI., USA
• Dr Mark Bulterys, Team Leader, Global Hepatitis Programme, World Health Organization, Geneva, Switzerland
• Dr Su Wang, President-Elect, World Hepatitis Alliance, Board Member, Hepatitis B Foundation, New York, USA
• Professor Markus Cornberg, Scientific Committee member, European Association for the Study of the Liver (EASL), Hannover, Germany
• Professor Fabien Zoulim, ICE-HBV Deputy Chair & Vice-President of the scientific advisory board and head of the HBV cure programme, French Agency for Research on AIDS and Viral Hepatitis (ANRS), Paris, France.
